DE602005021644D1 - Verfahren und reagentien zur diagnose von hantavirusinfektionen - Google Patents

Verfahren und reagentien zur diagnose von hantavirusinfektionen

Info

Publication number
DE602005021644D1
DE602005021644D1 DE602005021644T DE602005021644T DE602005021644D1 DE 602005021644 D1 DE602005021644 D1 DE 602005021644D1 DE 602005021644 T DE602005021644 T DE 602005021644T DE 602005021644 T DE602005021644 T DE 602005021644T DE 602005021644 D1 DE602005021644 D1 DE 602005021644D1
Authority
DE
Germany
Prior art keywords
hantavirus
methods
antigens
infection
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005021644T
Other languages
German (de)
English (en)
Inventor
Steve H Nguyen
Sergio Pichuantes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Novartis Vaccines and Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines and Diagnostics Inc filed Critical Novartis Vaccines and Diagnostics Inc
Publication of DE602005021644D1 publication Critical patent/DE602005021644D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/175—Bunyaviridae, e.g. California encephalitis virus, Rift valley fever virus, Hantaan virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE602005021644T 2004-06-18 2005-05-24 Verfahren und reagentien zur diagnose von hantavirusinfektionen Expired - Lifetime DE602005021644D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58102704P 2004-06-18 2004-06-18
PCT/US2005/018066 WO2006088478A2 (en) 2004-06-18 2005-05-24 Methods and reagents for diagnosing hantavirus infection

Publications (1)

Publication Number Publication Date
DE602005021644D1 true DE602005021644D1 (de) 2010-07-15

Family

ID=36916873

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005021644T Expired - Lifetime DE602005021644D1 (de) 2004-06-18 2005-05-24 Verfahren und reagentien zur diagnose von hantavirusinfektionen

Country Status (9)

Country Link
US (3) US7771730B2 (https=)
EP (1) EP1778880B1 (https=)
JP (2) JP4813471B2 (https=)
KR (1) KR20070026802A (https=)
CN (1) CN101163498B (https=)
AT (1) ATE469656T1 (https=)
DE (1) DE602005021644D1 (https=)
ES (1) ES2344150T3 (https=)
WO (1) WO2006088478A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2431148C1 (ru) * 2010-05-05 2011-10-10 Евгений Александрович Ткаченко Способ получения "диагностикума геморрагической лихорадки с почечным синдромом культурального, поливалентного для непрямого метода иммунофлюоресценции"
WO2012083475A1 (es) * 2010-12-20 2012-06-28 Universidad De Desarollo Anticuerpo policlonal neutralizante contra hantavirus andes, procedimiento de producción y composiciones farmacéuticas
CN112812184A (zh) 2011-02-25 2021-05-18 中外制药株式会社 FcγRIIb特异性Fc抗体
JP6322411B2 (ja) 2011-09-30 2018-05-09 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
CN102399265B (zh) * 2011-10-28 2014-06-25 中国人民解放军第四军医大学 Htnv-np 特异性的ctl 表位肽及其应用
RU2590606C2 (ru) * 2012-04-12 2016-07-10 Федеральное государственное бюджетное учреждение "Институт полиомиелита и вирусных энцефалитов им. М.П. Чумакова РАМН" Способ получения тест-системы "ханта-n" для определения специфической активности вакцины против геморрагической лихорадки с почечным синдромом
CN102731617B (zh) * 2012-05-05 2013-11-27 中国人民解放军第四军医大学 汉滩病毒糖蛋白特异性t细胞表位肽及其应用
RU2484478C1 (ru) * 2012-05-11 2013-06-10 Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Казанская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации Способ обнаружения антител к хантавирусу при геморрагической лихорадке с почечным синдромом и прогнозирование тяжелых форм заболевания
EP2857419B1 (en) * 2012-05-30 2021-01-13 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule for eliminating aggregated antigens
CN102731623B (zh) * 2012-06-08 2013-09-18 中国人民解放军第四军医大学 鼠源性单克隆抗体3d8识别的汉滩病毒糖蛋白中和表位肽及应用
NL2009515C2 (en) * 2012-09-25 2014-03-27 Europ Intelligence B V Mooring device for mooring a ship.
AU2014250434B2 (en) 2013-04-02 2019-08-08 Chugai Seiyaku Kabushiki Kaisha Fc region variant
RU2565543C2 (ru) * 2013-04-10 2015-10-20 Федеральное государственное бюджетное научное учреждение "Институт полиомиелита и вирусных энцефалитов им М.П. Чумакова " Способ получения иммуноферментной тест-системы для определения эпитопов оболочечного белка вируса пуумала протективной направленности в вакцинных препаратах против геморрагической лихорадки с почечным синдромом
US20140378329A1 (en) * 2013-06-24 2014-12-25 Idexx Laboratories, Inc. Animal Colony Monitoring Using Fecal Samples
CN106046125B (zh) * 2016-06-30 2020-04-24 中国人民解放军第四军医大学 Htnv gp上的ctl表位肽及其筛选方法和应用
KR102013954B1 (ko) * 2016-12-26 2019-08-23 주식회사 이뮨메드 서울바이러스와 푸말라바이러스 유래의 재조합 뉴클레오캡시드 단백질 및 한탄바이러스 유래의 재조합 당단백질을 포함하는 신증후군출혈열 진단용 조성물 및 이를 포함하는 진단 키트
CN107383176A (zh) * 2017-05-10 2017-11-24 于学杰 用于对汉滩病毒和汉城病毒引起的肾综合征出血热分型的多肽
CN110548136A (zh) * 2018-05-30 2019-12-10 王美亮 汉坦病毒长肽疫苗
CN109852588B (zh) * 2018-12-24 2023-03-07 中国水产科学研究院珠江水产研究所 一种抗罗非鱼免疫球蛋白IgM的单克隆抗体及其细胞株和应用
CN110042173A (zh) * 2019-02-28 2019-07-23 中国科学院广州生物医药与健康研究院 一种同时检测四种出血热病毒的纳米金生物传感器及检测方法
GB201910804D0 (en) * 2019-07-29 2019-09-11 Secetary Of State For Health And Socail Care Hantavirus antigenic Composition
KR102089268B1 (ko) * 2019-10-02 2020-03-16 대한민국 한탄바이러스 절단형 뉴클레오캡시드 단백질을 이용한 한탄바이러스 검출 방법
CN111333705A (zh) * 2019-12-06 2020-06-26 中国人民解放军第四军医大学 影响HTNV Gn胞质尾区的出胞表位序列的筛选及鉴定方法
CN114478719A (zh) * 2022-02-11 2022-05-13 中国人民解放军空军军医大学 一组汉坦病毒包膜糖蛋白的优势表位肽、其编码基因及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714556A (en) * 1981-06-29 1987-12-22 Ambrus Clara M Blood purification
US5298423A (en) 1987-11-25 1994-03-29 The United States Of America As Represented By The Secretary Of The Army Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins
JP2664471B2 (ja) * 1989-04-26 1997-10-15 鎬汪 李 腎症候性出血熱の診断用試薬
CA2166104A1 (en) * 1993-06-24 1995-01-05 Stuart T. Nichol Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection
US5837441A (en) 1993-08-25 1998-11-17 University Of New Mexico Hantavirus-associated respiratory distress virus antigens
US5853980A (en) 1995-02-17 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Black creek canal hantavirus and related methods
JPH10253634A (ja) * 1997-03-10 1998-09-25 Denki Kagaku Kogyo Kk クラミジア・トラコマティス抗体測定方法及び抗体測定試薬
US6136250A (en) * 1998-01-30 2000-10-24 Comair Rotron, Inc. Apparatus and method of encapsulating motors
US7217812B2 (en) 1999-01-29 2007-05-15 United States Of America As Represented By The Secretary Of The Army Extraneous DNA sequence that facilitates hantavirus gene expression
FR2794865B1 (fr) * 1999-06-09 2003-04-18 Pasteur Institut Methode de detection precoce des flavivirus et ses applications

Also Published As

Publication number Publication date
US7771730B2 (en) 2010-08-10
EP1778880A2 (en) 2007-05-02
JP4813471B2 (ja) 2011-11-09
WO2006088478A9 (en) 2007-03-08
US20110053140A1 (en) 2011-03-03
CN101163498B (zh) 2011-10-05
EP1778880B1 (en) 2010-06-02
US20130085264A1 (en) 2013-04-04
ATE469656T1 (de) 2010-06-15
EP1778880A4 (en) 2008-05-07
WO2006088478A3 (en) 2007-07-05
JP2008503720A (ja) 2008-02-07
KR20070026802A (ko) 2007-03-08
WO2006088478A2 (en) 2006-08-24
ES2344150T3 (es) 2010-08-19
CN101163498A (zh) 2008-04-16
US20080108051A1 (en) 2008-05-08
JP2011191322A (ja) 2011-09-29

Similar Documents

Publication Publication Date Title
DE602005021644D1 (de) Verfahren und reagentien zur diagnose von hantavirusinfektionen
Al Johani et al. MERS-CoV diagnosis: an update
Mattila et al. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms
EP3963070A4 (en) METHODS OF PREPARATION OF ANALYTES AND RELATED KITS
PH12020551371A1 (en) Assays to detect neurodegeneration
MX2013004305A (es) Metodos para determinar isotipos de anticuerpos anti-farmacos.
Maxwell et al. A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors
MA46814A1 (fr) Anticorps anti-lag3 radiomarqués pour imagerie immuno-pet
Lorusso et al. Discrepancies between feline coronavirus antibody and nucleic acid detection in effusions of cats with suspected feline infectious peritonitis
WO2016092096A1 (en) Anti-carbapenemase antibodies and uses thereof
Costa et al. Diagnosis of human strongyloidiasis: Application in clinical practice
Metanat et al. Acute Q fever among febrile patients in Zahedan, southeastern Iran
Alvarez et al. The efficacy of ELISA commercial kits for the screening of equine infectious anemia virus infection
WO2007132120A3 (fr) Procede et methodes de detection de la maladie d'alzheimer
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
TW200740840A (en) Diagnostic test kits
DE602006012033D1 (de) Verfahren zur messung immunsuppressiver tacrolimus-, sirolimus- und cyclosporin-a-komplexe in einer blutprobe
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
EA201491411A1 (ru) Растворимый manf при поражениях бета-клеток поджелудочной железы
Azatyan et al. Evaluation of IL-2, IL-10, IL-4 and ɤ-interferon levels in the oral fluids of patients with hepatitis C, B and HIV
Batskikh et al. Previous hepatitis B viral infection–an underestimated cause of pancreatic cancer
Martín-Escolano et al. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk
ATE454465T1 (de) In-vitro-verfahren zur identifizierung von verbindungen zur krebstherapie
Prabhakaran et al. A sensitive method to quantify HIV-1 antibodies in mucosal samples
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein